[{"address1": "22 Einstein Street", "address2": "Floor 4", "city": "Ness Ziona", "zip": "7414003", "country": "Israel", "phone": "972 7 2394 2377", "website": "https://www.biomx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.", "fullTimeEmployees": 58, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jonathan Eitan Solomon MBA", "age": 46, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 714367, "exercisedValue": 0, "unexercisedValue": 3978}, {"maxAge": 1, "name": "Dr. Merav  Bassan Ph.D.", "age": 57, "title": "Chief Development Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 437713, "exercisedValue": 0, "unexercisedValue": 1149}, {"maxAge": 1, "name": "Ms. Marina  Wolfson CPA", "age": 39, "title": "CFO & Secretary (Leave of Absence)", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 337514, "exercisedValue": 0, "unexercisedValue": 153}, {"maxAge": 1, "name": "Prof. Rotem  Sorek Ph.D.", "title": "Scientific Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eran  Elinav M.D., Ph.D.", "title": "Scientific Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 42, "title": "Scientific Founder", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Avraham  Gabay", "age": 37, "title": "Interim Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inbal  Benjamini-Elran", "title": "C.H.R.O", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Assaf  Oron", "age": 49, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 352037, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.422, "open": 0.4381, "dayLow": 0.4, "dayHigh": 0.4381, "regularMarketPreviousClose": 0.422, "regularMarketOpen": 0.4381, "regularMarketDayLow": 0.4, "regularMarketDayHigh": 0.4381, "beta": 1.309, "volume": 121993, "regularMarketVolume": 121993, "averageVolume": 447034, "averageVolume10days": 277080, "averageDailyVolume10Day": 277080, "bidSize": 900, "askSize": 2200, "marketCap": 29179076, "fiftyTwoWeekLow": 0.187, "fiftyTwoWeekHigh": 0.855, "fiftyDayAverage": 0.36114, "twoHundredDayAverage": 0.32785, "currency": "USD", "enterpriseValue": 19048178, "floatShares": 32388232, "sharesOutstanding": 69806400, "sharesShort": 168453, "sharesShortPriorMonth": 218126, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.0031, "heldPercentInsiders": 0.3845, "heldPercentInstitutions": 0.24937999, "shortRatio": 0.62, "shortPercentOfFloat": 0.0037, "bookValue": 0.067, "priceToBook": 6.238806, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -26169000, "trailingEps": -0.59, "enterpriseToEbitda": -0.778, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "PHGE", "underlyingSymbol": "PHGE", "shortName": "BiomX Inc.", "longName": "BiomX Inc.", "firstTradeDateEpochUtc": 1552483800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "79f496b8-a482-326c-9356-662c9a6d1300", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.418, "recommendationKey": "none", "totalCash": 14907000, "totalCashPerShare": 0.27, "ebitda": -24477000, "totalDebt": 15092000, "quickRatio": 1.391, "currentRatio": 1.578, "debtToEquity": 489.841, "returnOnAssets": -0.44904998, "returnOnEquity": -2.1699, "freeCashflow": -12319000, "operatingCashflow": -21286000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-06"}]